Please use this identifier to cite or link to this item:

TitleEmergent bacteria in cystic fibrosis : in vitro biofilm formation and resilience under variable oxygen conditions
Author(s)Lopes, Susana Patrícia
Azevedo, N. F.
Pereira, Maria Olívia
KeywordsOxygen limitation
Cystic fibrosis
Pseudomonas aeruginosa
Inquilinus limosus
Dolosignaulum pigrum
Biofilm resistance
Issue date2014
PublisherHindawi Publishing Corporation
JournalBiomed Research International
CitationLopes, Susana Patrícia; Azevedo, N. F.; Pereira, M. O., Emergent bacteria in cystic fibrosis: In vitro biofilm formation and resilience under variable oxygen conditions. BioMed Research International, 2014(678301), 1-7, 2014
Abstract(s)Concurrently to conventional bacterial pathogens, unusual microbes are emerging from cystic fibrosis (CF) airways. Nonetheless, little is known about the contribution of these newly microbes for the resilience of CF-associated biofilms, particularly under variable oxygen concentrations that are known to occur in vivo in the mucus of CF patients. Two CF-emergent bacterial species, Inquilinus limosus and Dolosigranulum pigrum, and the major pathogen Pseudomonas aeruginosa were studied in terms of biofilm development and antibiotic susceptibilities under in vitro atmospheres with different oxygen availabilities. All species were able to develop in vitro biofilms under different oxygen-available environments, with D. pigrum accumulating high amounts of biomass and respiratory activities. When established, biofilms were of difficult eradication, with antibiotics loosing their effectiveness in comparison with the corresponding planktonic populations. Surprisingly, biofilms of each emergent organism displayed multi-drug resistance under aerobic environments, enduring even in low-oxygen atmospheres. This study suggests a potential prospect on the impact of non-conventional organisms I. limosus and D. pigrum on CF lung infections, demonstrating capacity to adapt to biofilm mode of life under restricted-oxygen atmospheres resembling CF airways, which may ultimately endanger the efficacy of currently-used antibiotic regimens.
Publisher version
AccessOpen access
Appears in Collections:CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series

Files in This Item:
File Description SizeFormat 
document_17811_1.pdf345,66 kBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID